VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Addex Therapeutics Ltd (ADXN) Total Return Calculator with Dividends Reinvested

Addex Therapeutics Ltd

Popular:

The total return for Addex Therapeutics Ltd (ADXN) stock is -13.14% over the past 12 months. So far it's down 13.35% this year. The 5-year total return is -96.46%, meaning $10,000 invested in ADXN stock 5 years ago would be worth $354 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ADXN 1 year ago, it would be worth $8,873 today — you'd have lost $1,127.

With Dividends Reinvested$8,873-11.27%

Price Only (No DRIP)$8,873-11.27%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ADXN

1Y$8,686-$1,314 (-13.1%)-13.1% CAGR

3Y$4,801-$5,199 (-52.0%)-21.7% CAGR

5Y$354-$9,646 (-96.5%)-48.7% CAGR

10Y$310-$9,690 (-96.9%)-29.3% CAGR

15Y$310-$9,690 (-96.9%)-20.7% CAGR

20Y$310-$9,690 (-96.9%)-15.9% CAGR

30Y$310-$9,690 (-96.9%)-10.9% CAGR

Addex Therapeutics Ltd did not pay dividends during this period. Total return = price return.

Loading ADXN total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-13.35%	—	-13.35%	—	$8,665
1Y	-13.14%	-13.14%	-13.14%	—	$8,686
3Y	-51.99%	-21.70%	-51.99%	—	$4,801
5Y	-96.46%	-48.74%	-96.46%	—	$354
10Y	-96.90%	-29.34%	-96.90%	—	$310
15Y	-96.90%	-20.67%	-96.90%	—	$310
20Y	-96.90%	-15.94%	-96.90%	—	$310
30Y	-96.90%	-10.93%	-96.90%	—	$310

Risk & Highlights

Best Year+18.58%2020

Worst Year-90.57%2022

Max Drawdown-48.31%2025-10-17 → 2026-03-20

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-10.01%	-10.01%	—	+0.41%	-10.4pp
2025	+2.39%	+2.39%	—	+16.64%	-14.3pp
2024	+11.11%	+11.11%	—	+24.00%	-12.9pp
2023	-55.51%	-55.51%	—	+24.81%	-80.3pp
2022	-90.57%	-90.57%	—	-19.95%	-70.6pp

ADXN underperformed the S&P 500 by 43.51pp over the past year (-13.14% vs +30.37%).

Loading summary...

ADXN Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ADXNAddex Therapeutics Ltd	$5M	+14.9%	-13.3%	-13.1%	—	-52.0%	-96.5%	-96.9%
ACADACADIA Pharmaceuticals Inc.	$3.9B	+2.2%	-13.7%	+52.4%	—	+4.7%	+7.1%	-22.9%
INVAInnoviva, Inc.	$1.9B	-2.1%	+14.7%	+21.7%	—	+95.2%	+94.4%	+94.9%
PRAXPraxis Precision Medicines, Inc.	$9.6B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
NBIXNeurocrine Biosciences, Inc.	$15.0B	+14.3%	+6.4%	+23.0%	—	+52.8%	+64.3%	+233.2%
SAVACassava Sciences, Inc.	$94M	—	-6.5%	+25.3%	—	-40.8%	-67.0%	-19.5%
ANIKAnika Therapeutics, Inc.	$203M	+1.5%	+61.9%	+4.5%	—	-41.7%	-63.9%	-65.9%
NRXPNRx Pharmaceuticals, Inc.	$85M	+37.2%	+16.8%	+55.3%	—	-50.6%	-99.1%	-96.8%
LLYEli Lilly and Company	$921.2B	+4.7%	-9.6%	+26.3%	+0.8pp	+129.1%	+411.1%	+1237.7%
PFEPfizer Inc.	$150.6B	-2.3%	+6.9%	+23.7%	+7.5pp	-18.4%	-13.3%	+29.6%
ABBVAbbVie Inc.	$358.4B	-1.8%	-10.1%	+11.3%	+3.6pp	+50.4%	+101.3%	+295.5%

Compare:ADXN vs ACAD ADXN vs INVA ADXN vs PRAX ADXN vs ACAD vs INVA

About ADXN Dividend Returns

Addex Therapeutics Ltd (ADXN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ADXN over the past year?

Addex Therapeutics Ltd (ADXN) delivered a return of -13.14% over the past year. Since ADXN does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ADXN be worth today?

A $10,000 investment in Addex Therapeutics Ltd one year ago would be worth $8,686 today, representing a loss of $1,314.

Q3Does ADXN pay dividends?

Addex Therapeutics Ltd (ADXN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ADXN, the total return equals the price-only return.

Q4Did ADXN beat the S&P 500?

No, Addex Therapeutics Ltd (ADXN) underperformed the S&P 500 by 43.51 percentage points over the past year. ADXN delivered a total return of -13.14%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed ADXN by 43.51pp during this period.

Q5What is ADXN's worst drawdown?

Addex Therapeutics Ltd (ADXN) experienced a maximum drawdown of -48.31% over the past year, declining from its peak on 2025-10-17 to its trough on 2026-03-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ADXN's long-term total return over 10, 20, or 30 years?

Here are Addex Therapeutics Ltd (ADXN)'s long-term returns with dividends reinvested. Over 10 years, the total return is -96.9% (-29.3% CAGR) — $10,000 would have grown to $310. Over 20 years: -96.9% total return (-15.9% CAGR) — $10,000 → $310. Over 30 years: -96.9% total return (-10.9% CAGR) — $10,000 → $310. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ADXN's best and worst year?

Addex Therapeutics Ltd's best calendar year was 2020 with a total return of 18.6%. Its worst year was 2022 with a total return of -90.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 109.2 percentage points.